New ventures
We support researchers to build cancer-focused startups and spin-outs and secure investment through our extensive network.
Bridging the funding gap between cutting-edge ideas and treatments, diagnostics and medical devices.
At Cancer Research Horizons, we feel that too many great ideas arising from cancer research stall at the earliest stages of translation, delaying or even preventing much needed new innovations from reaching cancer patients.
Our fund exists to help bridge one of the most challenging stages of attracting the early stage risk capital to translate new cutting edge ideas, get a company launched and attract other, like-minded investors. Our fund brings innovative oncology ideas together with early stage capital, commercial advice, support with intellectual property, access to experts, mentors and management teams, and introductions to co-investors to maximise the chances of such ideas becoming financially attractive to investors and benefiting cancer patients.
You don't need to be a Cancer Research UK-funded researcher to secure capital from our fund. We're interested in all ideas that could benefit new cancer patients and fulfil our investment criteria, including new therapeutics, preventative measures, diagnostics, medical devices and AI/data driven solutions.
Reach out with your idea. Our team will work with you to assess the commercial potential of the spin-out opportunity and advise on the best way to proceed.
Throughout the whole process our expert team will support you to ensure we build the most compelling proposition. Depending on the stage, this could include access to our expert network, help with the concept and business plan, team training suggestions, smaller developmental capital to help de-risk the proposition or connecting with potential co-investors.
Once ready, we’ll assist you with completing the application documents and presenting the opportunity for consideration to our independent Investment Committee.
Once investment is approved, we'll work with you to put in place all required documentation, secure co-investors where applicable, and implement the investment under flexible models at pace.